EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab

Russell, J. S., & Colevas, A. D. (2012). The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck. Chemotherapy Research and Practice, 2012(), 172-184. https://doi.org/10.1155/2012/761518
Chuang, H. C., Chiu, T. J., Lin, Y. T., Huang, T. L., Fang, F. M., & Chien, C. Y. (2018). The Potential Role of Metformin in the Treatment of Head and Neck Squamous Cell Carcinoma. International Journal of Head and Neck Science, 2(2), 50-55. https://doi.org/10.6696/IJHNS.201806_2(2).0002
Lee, C. H., Wu, S. Y., Liu, I. T., Tsai, M. H., & Yen, C. J. (2018). The Emerging Role of Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. International Journal of Head and Neck Science, 2(2), 69-74. https://doi.org/10.6696/IJHNS.201806_2(2).0004
Hsu, M. L., Lee, J. C., Liu, C. J., Chen, Y. J., Chang, Y. F., & Leu, Y. S. (2021). Analysis of De Novo and Radiation-Induced Sarcomatoid Carcinoma of Head and Neck: A Single-Center Experience. International Journal of Head and Neck Science, 5(3), 105-110. https://doi.org/10.6696/IJHNS.202109_5(3).0003
王維吟、洪士涵、張燕良（2011）。Skin Metastases in Squamous Cell Carcinoma of the Head and Neck: A Retrospective Study and Review of Literatures。台灣耳鼻喉頭頸外科雜誌，46(1)，1-5。https://doi.org/10.6286/2011.46.1.1